Schedule 13D ownership disclosure

SENTI BIOSCIENCES INC

Common Stock, par value $0.0001 per share · CUSIP: 81726A100

Event date: 2025-03-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Bayer HealthCare LLCReported CIK 0001231517

    Shares: 6,142,848.00 · Class: 19.99%

  • Bayer US Holding LLCReported CIK 0001965754

    Shares: 6,142,848.00 · Class: 19.99%

  • Sebastian Guth

    Shares: 6,142,848.00 · Class: 19.99%

  • Gurumurthy Ramamurthy

    Shares: 6,142,848.00 · Class: 19.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-024530
Form type
SCHEDULE 13D
Filer
BAYER HEALTHCARE LLC
CIK
CIK 1231517
Filed
Mar 17, 2025
Reporting period
Mar 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub